A Double Blind Placebo Controlled Study of Atorvastatin as Prevention of CHD in High Risk Patients With Non-Insulin Dependent Diabetes Mellitus (Collaborative Atorvastatin Study - CARDS)
A Double Blind Placebo Controlled Study of Atorvastatin as Prevention of CHD in High Risk Patients With Non-Insulin Dependent Diabetes Mellitus (Collaborative Atorvastatin Study - CARDS)
A study to assess the efficacy of once daily atorvastatin 10 mg versus placebo on cardiovascular endpoints in patients with non-insulin-dependent diabetes mellitus (NIDDM) who have a history of either hypertension, retinopathy, microalbuminuria, macroalbuminuria, or who currently smoke, but who do not have established corornary heart disease or other macrovascular disease.
Inclusion Criteria:
Patients must have a documented history of at least one of the following:
Exclusion Criteria:
Fosterhill, Aberdeen AB25 2XG, United Kingdom
Bocastle, Cornwall PL35 0BG, United Kingdom
Crownhill, Plymouth, DEVON PL5 3JB, United Kingdom
Co. Dublin, United Kingdom
Hertfordshire, AL7 4HQ, United Kingdom
Hertfordshire, SG1 4AB, United Kingdom
Wiltshire, BA15 1DQ, United Kingdom
Wiltshire, SN12 7EA, United Kingdom
Wiltshire, SP2 8BJ, United Kingdom